Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Almac Group, a Craigavon, UK-based contract development and manufacturing organization (CDMO) of active pharmaceutical ingredients (APIs) and drug products, has appointed David Taylor as Head of Manufacturing Operations. Taylor joined the Almac...

CordenPharma, a contract development and manufacturing organization of active pharmaceutical ingredients (APIs) and drug products, has expanded its commercial oligonucleotide API manufacturing at its CordenPharma Colorado site in Boulder,...

Catalent Pharma Solutions has made leadership changes within its biologics business. The changes follows its $950-million acquisition in 2017 of Cook Pharmica, a Bloomington, Indiana contract development and manufacturing organization of biologic...

Camargo Pharmaceutical Services, a Cincinnati, Ohio-based provider of drug-development services, including 505(b)(2) drug development and global equivalents, has appointed Daniel S. Duffy as the firm’s new Chief Executive Officer. Kenneth V....

Avid Bioservices, a Tustin, California-based contract development and manufacturing organization (CDMO) of biopharmaceutical products derived from mammalian cell culture and a wholly owned subsidiary of Peregrine Pharmaceuticals, has provided an...

STA Pharmaceutical, a subsidiary of WuXi AppTec, has signed an investment agreement with the government of Shanghai, Jinshan District, China to build a new research & development (R&D) center. The new facility will support WuXi STA’s...

Cell and Gene Therapy Catapult (CGT Catapult), a center of excellence funded by Innovate UK, the UK government’s innovation agency, to support cell-therapy organizations, has opened a cell- and gene- therapy manufacturing center in Stevenage,...

Dipharma, a Baranzate, Italy-headquartered active pharmaceutical ingredients manufacturer, has agreed to acquire Kalexsyn, a Kalamazoo, Michigan-headquartered contract research organization (CRO) providing chemistry services to the biotechnology...

AMRI, a contract research, development, and manufacturing organization, has renewed a 10-year contract worth up to $39.5 million with the National Institutes of Health (NIH) Blueprint Neurotherapeutics Network (BPN). The renewal means AMRI will...